Schedule 13G Amendment No. 4

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 4)*

 

 

China Biologic Products, Inc. (the “Issuer”)

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

16938C106

(CUSIP Number)

June 4, 2012

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 16938C106   Page 2 of 12

 

  1   

NAMES OF REPORTING PERSONS

 

IDG-Accel China Growth Fund II L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Cayman Islands

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    0

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    0

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ¨

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0.0%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    PN


CUSIP No. 16938C106   Page 3 of 12

 

  1   

NAMES OF REPORTING PERSONS

 

IDG-Accel China Growth Fund II Associates L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Cayman Islands

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    0

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    0

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ¨

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0.0%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    PN


CUSIP No. 16938C106   Page 4 of 12

 

  1   

NAMES OF REPORTING PERSONS

 

IDG-Accel China Investors II L.P.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Cayman Islands

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    0

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    0

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ¨

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0.0%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    PN


CUSIP No. 16938C106   Page 5 of 12

 

  1   

NAMES OF REPORTING PERSONS

 

IDG-Accel China Growth Fund GP II Associates Ltd.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Cayman Islands

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    0

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    0

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ¨

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0.0%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    CO


CUSIP No. 16938C106   Page 6 of 12

 

  1   

NAMES OF REPORTING PERSONS

 

Quan Zhou

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    0

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    0

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ¨

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0.0%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    IN


CUSIP No. 16938C106   Page 7 of 12

 

  1   

NAMES OF REPORTING PERSONS

 

Chi Sing Ho

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Canada

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

     

SOLE VOTING POWER

 

    0

   6   

SHARED VOTING POWER

 

    0

   7   

SOLE DISPOSITIVE POWER

 

    0

   8   

SHARED DISPOSITIVE POWER

 

    0

  9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    0

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    ¨

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

    0.0%

12

 

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

    IN


CUSIP No. 16938C106   SCHEDULE 13G   Page 8 of 12 Pages

Explanatory Note

 

This Amendment No. 4 amends the Schedule 13G filed by each of the reporting persons except for Chi Sing Ho on July 15, 2009, as amended on February 2, 2010, February 10, 2011 and February 9, 2012. This Amendment No. 4 also amends the Schedule 13G filed by Chi Sing Ho on March 29, 2012 relating to his beneficial ownership in common stock of the Issuer held of record by IDG-Accel China Growth Fund II L.P. and IDG-Accel China Investors II L.P.

Item 1(a)   

Name of Issuer:

     
  

China Biologic Products, Inc.

     
Item 1(b)   

Address of Issuer’s Principal Executive Offices:

     
  

No. 14 East Hushan Road, Taian City, Shandong

     
  

People’s Republic of China 271000

     
Item 2(a)   

Name of Person Filing:

     
  

1. IDG-Accel China Growth Fund II L.P.

     
  

2. IDG-Accel China Growth Fund II Associates L.P.

     
  

3. IDG-Accel China Investors II L.P.

     
  

4. IDG-Accel China Growth Fund GP II Associates Ltd.

     
  

5. Chi Sing Ho

     
  

6. Quan Zhou

     
  

The above persons have agreed to jointly file this statement pursuant to Rule 13d-1(k). A copy of such agreement is attached as an exhibit to this statement.

     
  

IDG-Accel China Growth Fund II L.P. is a limited partnership organized under the laws of the Cayman Islands. The general partner of IDG-Accel China Growth Fund II L.P. is IDG-Accel China Growth Fund II Associates L.P., a limited partnership organized under the laws of the Cayman Islands. The general partner of IDG-Accel China Growth Fund II Associates L.P. is IDG-Accel China Growth Fund GP II Associates Ltd., a limited liability company incorporated under laws of the Cayman Islands. IDG-Accel China Investors II L.P. is a limited partnership organized under the laws of the Cayman Islands. The general partner of IDG-Accel China Investors II L.P. is IDG-Accel China Growth Fund GP II Associates Ltd. The directors of IDG-Accel China Growth Fund GP II Associates Ltd. are Chi Sing Ho and Quan Zhou.

     
Item 2(b)   

Address of Principal Business Office or, If None, Residence; Citizenship

     
  

For all reporting persons:

     
  

c/o IDG VC Management Ltd.

     
  

Unit 1509, The Center

     
  

99 Queen’s Road

     
  

Central, Hong Kong

     
Item 2(c)    Citizenship   
   Chi Sing Ho is a citizen of Canada. Quan Zhou is a citizen of United States of America. Each of IDG-Accel China Growth Fund II L.P., IDG-Accel China Growth Fund II Associates L.P., IDG-Accel China Investors II L.P. and IDG-Accel China Growth Fund GP II Associates Ltd. is organized under the laws of the Cayman Islands.   
Item 2(d)    Title of Class of Securities:   
   Common stock, par value $0.0001 per share   
Item 2(e)    CUSIP Number:   
   16938C106   
Item 3.    Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c):   
   Not applicable.   


CUSIP No. 16938C106   SCHEDULE 13G   Page 9 of 12 Pages

 

Item 4.    Ownership      
   The information for each reporting person contained in Items 5-11 of the cover pages is incorporated herein by reference.   
Item 5.    Ownership of Five Percent or Less of a Class   
   If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  x.   
Item 6.    Ownership of More Than Five Percent on Behalf of Another Person      
   Not applicable.      
Item 7.    Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
   Not applicable.
Item 8.    Identification and Classification of Members of the Group      
   Not applicable.      
Item 9.    Notice of Dissolution of Group      
   Not applicable.      
Item 10.    Certifications      
   Not applicable.      


CUSIP No. 16938C106   SCHEDULE 13G   Page 10 of 12 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: June 5, 2012

 

IDG-ACCEL CHINA GROWTH FUND II L.P.

  By: IDG-Accel China Growth Fund II Associates L.P.,

  its General Partner

  By: IDG-Accel China Growth Fund GP II Associates Ltd.,

  its General Partner

By:  

/s/ Quan ZHOU

  Name:   Quan ZHOU
  Title:   Authorized Signatory

IDG-ACCEL CHINA GROWTH FUND II ASSOCIATES L.P.

  By: IDG-Accel China Growth Fund GP II Associates Ltd.,

  its General Partner

By:  

/s/ Quan ZHOU

  Name:   Quan ZHOU
  Title:   Authorized Signatory
IDG-ACCEL CHINA GROWTH FUND GP II ASSOCIATES LTD.
By:  

/s/ Quan ZHOU

  Name:   Quan ZHOU
  Title:   Authorized Signatory

IDG-ACCEL CHINA INVESTORS II L.P.

  By: IDG-Accel China Growth Fund GP II Associates Ltd.,

  its General Partner

By:  

/s/ Quan ZHOU

  Name:   Quan ZHOU
  Title:   Authorized Signatory
QUAN ZHOU
By:  

/s/ Quan ZHOU

CHI SING HO
By:  

/s/ Chi Sing HO


CUSIP No. 16938C106   SCHEDULE 13G   Page 11 of 12 Pages

LIST OF EXHIBITS

 

Exhibit
No.

  

Description

A    Joint Filing Agreement